SCREEN-ERR is a service designed to help companies evaluate multiple pharmaceutical
trademark candidates at an early phase of trademark development. Once preliminary legal
screening has taken place, SCREEN-ERR can determine whether any regulatory or other
concerns exist which may result in a name deemed unacceptable to regulatory health
authorities. It can be performed using global information resources, but SCREEN-ERR can
be tailored to specific territories of interest.
SCREEN-ERR looks for obvious and potential regulatory conflicts. It is not intended to
replace or supercede the
of safety testing, which incorporates a different range of criteria such as
handwritten and verbal confusability of trademarks. It does consider
each trademark candidate, providing a "green-yellow-red" rating of acceptability.
For our clients, SCREEN-ERR offers an efficient way to identify unacceptable candidates, saving both time and money.